CCR8 is a chemokine receptor that has recently been identified as a potential specific marker for tumor-infiltrating Tregs (110) and a core member of the interferon regulatory factor 4 (IRF4)-dependent “effector” Treg gene program (111). Here, IRF4 is linked to neoplasm.